Senior Lecturer and Group Leader, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University
Dr May leads the Cardiac GPCR Biology laboratory at Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. Dr May uses her molecular pharmacology expertise to apply new and innovative drug discovery approaches to facilitate the development of safe and effective therapeutics. She employs multidisciplinary methods to achieve these research goals, including artificial intelligence, computational biology, and molecular and analytical pharmacology. Dr. May has secured significant competitive funding, which has led to impactful publications in Nature, Cell, Nature Machine Intelligence, Nature Communications, and Proc. Natl. Acad. Sci. USA.
Dr May is committed to improving health outcomes as advisory member for the Australian Cardiovascular Alliance Drug Discovery Flagship and inaugural Chair of the Monash Institute of Pharmaceutical Sciences Climate Health Initiative. Dr May is an advocate for diversity in science, co-founder and past chair of Her Research Matters (2021 Monash University Vice-Chancellor’s Award for Excellence in Diversity and Inclusion) and a member of the 2019 International Women’s Forum (IWFA) Emerging Leaders Cohort.